Redwood City, CA, United States of America

Leila Marie Boustany

This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Pfizer Corporation, Cytomx Therapeutics, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leila Marie Boustany. Retrieved from https://idiyas.com/inventor/leila-marie-boustany

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Leila Marie Boustany - Innovative Inventor from Redwood City

Introduction: Leila Marie Boustany is a pioneering inventor based in Redwood City, California, known for her groundbreaking contributions to various fields of technology and science.

Latest Patents: Leila Marie Boustany holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Leila Marie Boustany has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation and creating solutions to complex problems.

Collaborations: Throughout her career, Leila Marie Boustany has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all her projects.

Conclusion: Leila Marie Boustany's passion for innovation and her relentless drive to make a positive impact on the world through her inventions truly sets her apart as a visionary inventor in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…